Product
PPIs IV infusion
1 clinical trial
1 indication
Indication
Peptic UlcerClinical trial
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic HemostasisStatus: Completed, Estimated PCD: 2022-12-01